Literature DB >> 7732025

Peptide mimicry of the meningococcal group C capsular polysaccharide.

M A Westerink1, P C Giardina, M A Apicella, T Kieber-Emmons.   

Abstract

Sequence analysis of the variable regions of the heavy and light chains of the anti-idiotypic antibody 6F9, which mimics the meningococcal group C capsular polysaccharide (MCP), was performed. The immunogenic site on 6F9 responsible for inducing an anti-MCP antibody response was determined by means of sequence and computer model analysis of these data. Complementarity-determining region 3 (CDR3) was found to be unique in that the sequence tract YRY was exposed on the surface. A synthetic peptide spanning the CDR3 domain was synthesized and complexed to proteosomes (meningococcal group B outer membrane protein). Immunizations of BALB/c mice with the peptide-proteosome complex resulted in a significant anti-MCP antibody response. Immunized mice were protected against infection with a lethal dose of Neisseria meningitidis serogroup C.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7732025      PMCID: PMC42094          DOI: 10.1073/pnas.92.9.4021

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Cell fusion.

Authors:  R H Kennett
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

2.  Molecular characterization and structural modeling of immunoglobulin variable regions from murine monoclonal antibodies specific for hepatitis B virus surface antigen.

Authors:  K L Lohman; T Kieber-Emmons; R C Kennedy
Journal:  Mol Immunol       Date:  1993-10       Impact factor: 4.407

3.  The Protein Data Bank: a computer-based archival file for macromolecular structures.

Authors:  F C Bernstein; T F Koetzle; G J Williams; E F Meyer; M D Brice; J R Rodgers; O Kennard; T Shimanouchi; M Tasumi
Journal:  J Mol Biol       Date:  1977-05-25       Impact factor: 5.469

Review 4.  Knowledge-based prediction of protein structures and the design of novel molecules.

Authors:  T L Blundell; B L Sibanda; M J Sternberg; J M Thornton
Journal:  Nature       Date:  1987 Mar 26-Apr 1       Impact factor: 49.962

5.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

6.  [The primary structure of the alpha-amylase inhibitor Hoe 467A from Streptomyces tendae 4158. A new class of inhibitors].

Authors:  H Aschauer; L Vértesy; G Nesemann; G Braunitzer
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1983-10

7.  Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.

Authors:  W D Zollinger; R E Mandrell; J M Griffiss; P Altieri; S Berman
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse bacteremia model.

Authors:  D E Craven; C E Frasch
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  20 in total

1.  Induction of a protective capsular polysaccharide antibody response to a multiepitope DNA vaccine encoding a peptide mimic of meningococcal serogroup C capsular polysaccharide.

Authors:  Deborah M Prinz; S Louise Smithson; Thomas Kieber-Emmons; M A Julie Westerink
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

2.  Identification and characterization of peptide mimics of blood group A antigen.

Authors:  Zhaoming Tang; Lin Wang; Lihua Hu; Yirong Li; Tianpen Cui; Juan Xiong; Lifang Dou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-05-15

3.  Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae.

Authors:  S L Harris; M K Park; M H Nahm; B Diamond
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Natural human anti-Gal alpha(1,3)Gal antibodies react with human mucin peptides.

Authors:  M S Sandrin; H A Vaughan; P X Xing; I F McKenzie
Journal:  Glycoconj J       Date:  1997-01       Impact factor: 2.916

5.  Exploring the basis of peptide-carbohydrate crossreactivity: evidence for discrimination by peptides between closely related anti-carbohydrate antibodies.

Authors:  S L Harris; L Craig; J S Mehroke; M Rashed; M B Zwick; K Kenar; E J Toone; N Greenspan; F I Auzanneau; J R Marino-Albernas; B M Pinto; J K Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.

Authors:  In Ho Park; Ju Ho Youn; In-Hong Choi; Moon H Nahm; Se Jong Kim; Jeon-Soo Shin
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Monoclonal antibodies specific for Neisseria meningitidis group B polysaccharide and their peptide mimotopes.

Authors:  J S Shin; J S Lin; P W Anderson; R A Insel; M H Nahm
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

8.  Peptide inhibition of glomerular deposition of an anti-DNA antibody.

Authors:  B Gaynor; C Putterman; P Valadon; L Spatz; M D Scharff; B Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

Review 9.  Peptide mimotopes of carbohydrate antigens.

Authors:  T Kieber-Emmons
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

10.  Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci.

Authors:  N D Russell; J R Corvalan; M L Gallo; C G Davis; L a Pirofski
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.